RICHMOND, Va. , Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37 th Annual Healthcare Conference: Piper Sandler 37 th Annual Healthcare Conference – New York City , NY Joe Ciaffoni , Chief Executive Officer, and Ryan Preblick , Chief Financial Officer, will host 1x1 / group meetings on Tuesday, December 2 nd . Joe Ciaffoni and Ryan Preblick will also... Read More

Medicaid and commercially insured patients with high adherence to SUBLOCADE® experienced lower relapse rates and reduced healthcare resource utilization Adherence to SUBLOCADE was associated with lower rates of infectious disease complications and improved chronic disease management in people with opioid use disorder (OUD) RICHMOND, Va. , Nov. 3, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) presented three new scientific... Read More

Rapid induction with SUBLOCADE® showed higher treatment retention rates compared to standard induction, particularly among fentanyl-positive participants RICHMOND, Va. , Oct. 15, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) this week published compelling results from a multicenter, open-label clinical trial published in JAMA Network Open . Two approaches were evaluated for initiating treatment with SUBLOCADE ® ,... Read More

RICHMOND, Va. , Aug. 20, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the following investor events: Morgan Stanley 23 rd Annual Global Healthcare Conference – New York City , NY Joe Ciaffoni , Chief Executive Officer, and Ryan Preblick , Chief Financial Officer, will host 1x1 / group meetings on Monday, September 8 th . Joe Ciaffoni will also participate in a fireside... Read More

Q2'25 Total Net Revenue of $302m ; Q2'25 SUBLOCADE® Net Revenue of $209m , up 9% Year-over-Year Indivior Action Agenda Underway to Strengthen Business and Generate Operational Momentum Conference Call Scheduled for Today at 8:00 A.M. EDT RICHMOND, Va. , July 31, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today reported its financial results for the second quarter ended June 30, 2025, and provided a business update.... Read More